51. Amer ME, El-Sayed SZ, El-Kheir WA, et al. Clinical and laboratory
evaluation of patients with endstage liver cell failure injected with bone marrow-
derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011; 23(10): 936-
941. doi: 10.1097/MEG.0b013e3283488b00.
52. Venkataramana NK, Kumar SK, Balaraju S, et al. Open-labeled study of
unilateral
autologous
bone-marrow-derived
mesenchymal
stem
cell
transplantation in Parkinson’s disease. Transl Res. 2010; 155(2): 62-70. doi:
10.1016/j.trsl.2009.07.006.
53. Geffner L, Montenegro X, Bassanini M, et al. Transplant of autologous
bone marrow stem cells into Parkinson’s disease patients is safe and may improve
their quality of life. XVIII World Federation of Neurology Congress on
Parkinson’s Disease and Related Disorders. Parkinson’s Disease and Related
Disorders. 2009; 15(S2): 124.
54. Bhansali A, Asokumar P, Walia R, et al. Efficacy and safety of
autologous bone marrow-derived stem cell transplantation in patients with type 2
diabetes mellitus: a randomized placebo-controlled study. Cell Transplant. 2014;
23(9): 1075-1085.
55. Wu Z, Cai J, Chen J, et al. Autologous bone marrow mononuclear cell
infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: An open-
label, randomized controlled clinical trial. Cytotherapy. 2014; 16(2): 258-265.
doi: 10.1016/j.jcyt.2013.10.004.
56. Mesples A, Majeed N, Zhang Y, Hu X. Early immunotherapy using
autologous adult stem cells reversed the effect of anti-pancreatic islets in recently
diagnosed type 1 diabetes mellitus: preliminary results. Med Sci Monit. 2013; 19:
852-857. doi: 10.12659/MSM.889525.
57. Park SS, Bauer G, Abedi M, et al. Intravitreal autologous bone marrow
cd34+ cell therapy for ischemic and degenerative retinal disorders: preliminary
phase 1 clinical trial findings. Invest Ophthalmol Vis Sci. 2014; 56(1): 81-89. doi:
10.1167/iovs.14-15415.
58. Weiss JN, Levy S, Benes SC. Stem cell ophthalmology treatment study
(SCOTS) for retinal and optic nerve diseases: a case report of improvement in
